Sustained-release nanocapsule based on a 3D COF for long-term enzyme prodrug therapy of cancer

Chem Commun (Camb). 2022 May 12;58(39):5877-5880. doi: 10.1039/d2cc00373b.

Abstract

A well-designed three-dimensional (3D) covalent organic framework (COF) was constructed as a nanocapsule for the encapsulation of horseradish peroxidase (HRP), which could realize sustained release of HRP to prolong the duration of the therapeutic agents and promote long-term enzyme prodrug therapy.

MeSH terms

  • Delayed-Action Preparations
  • Horseradish Peroxidase
  • Humans
  • Metal-Organic Frameworks*
  • Nanocapsules*
  • Neoplasms*
  • Prodrugs* / pharmacology
  • Prodrugs* / therapeutic use

Substances

  • Delayed-Action Preparations
  • Metal-Organic Frameworks
  • Nanocapsules
  • Prodrugs
  • Horseradish Peroxidase